TY - JOUR
T1 - Impact pathways
T2 - improving medicine access through cross-national stockpiling
AU - De Vries, Harwin
AU - Lemmens, Stef
AU - Breugem, Thomas
AU - Olivier, Max
N1 - Publisher Copyright: © 2024, Harwin De Vries, Stef Lemmens, Thomas Breugem and Max Olivier.
PY - 2024/12/16
Y1 - 2024/12/16
N2 - Purpose: Pressure to address drug shortages is increasing, and calls for cross-national stockpiling solutions are on the rise. This paper argues that cross-national stockpiling presents an important opportunity for operations and supply chain management (OSCM) research to help improve medicine access in the short- and long-term. Design/methodology/approach: To substantiate our claims for future research, we conducted an empirical analysis of shortage co-occurrence on twelve EU member-states, reviewed practice reports and academic literature, and held extensive discussions with pharmaceutical supply chain stakeholders. Findings: We show that the potential for cross-national stockpiling is unmistakably there and that, although OSCM research has touched upon important facets of cross-national stockpiling, many open questions still require novel research. Originality/value: We present opportunities for impactful research along various dimensions, including understanding barriers and stakeholder behavior, quantifying cost-effectiveness and potential knock-on effects, analyzing the positive and negative implications of product standardization and determining novel equitable mechanisms for allocation and financing cross-national stockpiles.
AB - Purpose: Pressure to address drug shortages is increasing, and calls for cross-national stockpiling solutions are on the rise. This paper argues that cross-national stockpiling presents an important opportunity for operations and supply chain management (OSCM) research to help improve medicine access in the short- and long-term. Design/methodology/approach: To substantiate our claims for future research, we conducted an empirical analysis of shortage co-occurrence on twelve EU member-states, reviewed practice reports and academic literature, and held extensive discussions with pharmaceutical supply chain stakeholders. Findings: We show that the potential for cross-national stockpiling is unmistakably there and that, although OSCM research has touched upon important facets of cross-national stockpiling, many open questions still require novel research. Originality/value: We present opportunities for impactful research along various dimensions, including understanding barriers and stakeholder behavior, quantifying cost-effectiveness and potential knock-on effects, analyzing the positive and negative implications of product standardization and determining novel equitable mechanisms for allocation and financing cross-national stockpiles.
UR - http://www.scopus.com/inward/record.url?scp=85212095312&partnerID=8YFLogxK
U2 - 10.1108/IJOPM-07-2024-0550
DO - 10.1108/IJOPM-07-2024-0550
M3 - Article
AN - SCOPUS:85212095312
SN - 0144-3577
VL - 44
SP - 364
EP - 372
JO - International Journal of Operations and Production Management
JF - International Journal of Operations and Production Management
IS - 13
ER -